EXMceuticals (STU:9OM1) Common Stock : €13.39 Mil (As of Mar. 2021)

View and export this data going back to 2019. Start your Free Trial

What is EXMceuticals Common Stock?

EXMceuticals's quarterly common stock stayed the same from Sep. 2020 (€12.78 Mil) to Dec. 2020 (€12.78 Mil) but then increased from Dec. 2020 (€12.78 Mil) to Mar. 2021 (€13.39 Mil).

EXMceuticals's annual common stock increased from Jun. 2018 (€1.58 Mil) to Jun. 2019 (€7.65 Mil) and increased from Jun. 2019 (€7.65 Mil) to Jun. 2020 (€7.98 Mil).

EXMceuticals Common Stock Historical Data

The historical data trend for EXMceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Common Stock Chart

EXMceuticals Annual Data

Trend

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Common Stock

Get a 7-Day Free Trial

1.17

1.58

7.65

7.98

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Common Stock	Get a 7-Day Free Trial															7.59	7.98	12.78	12.78	13.39

EXMceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

EXMceuticals (STU:9OM1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (STU:9OM1) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9

Website

http://www.exmceuticals.com

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (STU:9OM1) Headlines

No Headlines